Síndrome de Guillain-Barré tras vacunación contra SARS-CoV-2 con Sinovac®
https://doi.org/10.22379/24224022365

PDF
XML

Citas

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268-70. DOI: 10.1056/NEJMc2008597.

Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, Bauer C, Hautefort C, et al. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020; 20(9):1015-6. https://doi.org/10.1016/S1473-3099(20)30293-0.

Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6. DOI: 10.1056/NEJMc2009191.

Zhao H, Shen D, Zhou H, Liu J, Sheng Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-4. https://doi.org/10.1016/S1474-4422(20)30109-5.

Vergara JP, Tolosa C. Covid-19: manifestaciones neurológicas. Acta Neurol Colomb. 2020;36(Supl. 1):7-10.

Parra B; Lizarazo J; Jiménez-Arango J; Zea-Vera A; González-Manrique G; José Vargas J, et al. Guillain-Barré syndrome associated with Zika virus infection in Colombia. N Engl J Med. 2016;375:1513-23 DOI: 10.1056/NEJMoa1605564.

Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus 13(2): e13426. DOI 10.7759/cureus.13426.

Márquez A, Holroyd K, Johnson S, Pilgrim DM, Amato AA. Guillain-Barré syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: Temporal associations do not imply causality. Neurology. 2021 Apr 6; DOI : 10.1212/WNL.0000000000011881.

Dufour C, Co T, Liu A. GM1 ganglioside antibody and COVID-19 related Guillain Barre Syndrome - A case report, systemic review and implication for vaccine development. Brain Behav Immun Health. 2021 Mar;12:100203. doi: 10.1016/j.bbih.2021.100203.

Lunn M, Cornblath D, Jacobs B, Querol L, van Doorn P, Hughes R, Willison H. COVID-19 vaccine and Guillain-Barré syndrome: Let's not leap to associations. Brain. 2021;144(2):357-60.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Descargas

Los datos de descargas todavía no están disponibles.